(Q43753310)

26 November 2017

title

A double-blind trial on the effects of atorvastatin on glycemic control in Japanese diabetic patients with hypercholesterolemia (English)

1 reference

26 November 2017

0 references

A Tanaka

1

1 reference

26 November 2017

N Yamada

2

1 reference

26 November 2017

Y Saito

3

1 reference

26 November 2017

M Kawakami

4

1 reference

26 November 2017

Y Ohashi

5

1 reference

26 November 2017

Y Akanuma

6

1 reference

26 November 2017

publication date

1 October 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

312

1 reference

26 November 2017

issue

1-2

1 reference

26 November 2017

page(s)

41-47

1 reference

Comparative effects of HMG-CoA reductase inhibitors on apo B production in the casein-fed rabbit: atorvastatin versus lovastatin

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900589-7

Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900589-7

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900589-7

Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900589-7

Detection and management of lipid disorders in diabetic patients. A commentary for clinicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900589-7

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900589-7

Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900589-7

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900589-7

The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900589-7

Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900589-7

10.1016/S0009-8981(01)00589-7

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference